-
Natural Products From Traditional Chinese Medicine: Potential Therapeutic Agents in Cancer Therapy-Induced Cardiotoxicity
02 Sep 2025 16:45 GMT
… acute leukemias, lymphomas, breast cancers, gastric cancers, soft-tissue sarcomas, and … including small-cell lung cancer, ovarian cancer, lymphoma, and germ cell … ejca.2023.02.019
61. Kong C, Guo Z, Song … Wu W, Cui Y, Hong Y, et al. Doxorubicin cardiomyopathy …
-
Zai Lab announces approval of TIVDAK in Hong Kong
02 Sep 2025 09:12 GMT
… recurrent or metastatic cervical cancer with disease progression … recurrent or metastatic cervical cancer after initial therapy … conjugate therapy in cervical cancer, delivers a clinically … infrastructure for ZEJULA in Hong Kong, we are uniquely positioned …
-
Bail for 2 Hong Kong doctors accused of leaking data to implicate surgeon
02 Sep 2025 07:37 GMT
… bail after being arrested in Hong Kong on suspicion of leaking a … data of a female pancreatic cancer patient who died after a …
-
Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong
02 Sep 2025 03:55 GMT
… conjugate (ADC) therapy in cervical cancer, delivers a clinically meaningful survival … in Greater China (mainland China, Hong Kong, Macau, and Taiwan, collectively).
About … the potential treatment of cervical cancer. These forward-looking statements may …
-
Race Oncology opens first Hong Kong site for RC220 Phase 1 solid...
02 Sep 2025 00:41 GMT
… commenced, with the first Hong Kong patient expected to begin … This will establish a second Hong Kong recruitment site.
“Activating the … patient being treated in Hong Kong.”
Patients already treated in … RC220 at the Southside Cancer Care Centre in Miranda, …
-
Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy
02 Sep 2025 08:44 GMT
HONG KONG, Sept. 2, 2025 / … current standard therapies for various cancers), or VEGF-related treatments, … therapy ):
First-line biliary tract cancer (versus durvalumab + chemotherapy)
First … assets in the fields of cancer, autoimmune disease, inflammation, …
-
Two Hong Kong doctors arrested over leaking patient information
01 Sep 2025 11:57 GMT
Two Hong Kong doctors at a public hospital … he said that the (HA), Hong Kong’s public hospital operator, had … third party without authorisation.
The Hong Kong Police Force headquarters in Wan … a patient with terminal pancreatic cancer who died after surgery at …
-
A September Shiver on Wall Street
02 Sep 2025 19:29 GMT
… ground yesterday. Mainland China and Hong Kong are reversing course after yesterday … ER+/HER2- metastatic breast cancer, with Olema leading the study …
-
HKMU licenses tech for non-invasive prostate cancer screening
29 Aug 2025 11:01 GMT
… point-of-care diagnostic platform
Hong Kong Metropolitan University (HKMU) recently … decisions for prostate cancer, ultimately benefiting patients.
Prostate cancer is the … enables the screening of multiple cancer biomarkers simultaneously using advanced …
-
Montpellier-based SeqOne acquires Cambridge-based Congenica to create a global leader in AI-powered genomic medicine
02 Sep 2025 16:20 GMT
… as Genomics England and the Hong Kong Genomic Programme.
Founded in 2017 … and enabling more precise, personalised cancer therapies.
This move comes at …